Market Access Heard on the pipeline: Access to medications Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years.
R&D Reuters Pharma USA 2024 – Moreno Perugini Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Digital Reuters Pharma USA 2024 – Serena Goodwin AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.
Digital Reuters Pharma USA 2024 – Nick Altebrando and Shireen Saxena When it comes to patient-facing AI in healthcare, ChatGPT, with its tendency toward hallucination, is not going to cut it.
R&D Reuters Pharma USA 2024 – Jeffrey Meckler Most of the exciting work being done right now in cancer immunotherapy is centred on highly targeted approaches that aim to activate only the most necessary immune responses to eliminate a
R&D Reuters Pharma USA 2024 – Lung-I Cheng Cell and gene therapies were a major topic of discussion this year at Reuters Pharma USA in Philadelphia.
News Daiichi and AZ pull Dato-DXd filing in Europe too AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
